0001156039-24-000109.txt : 20240723
0001156039-24-000109.hdr.sgml : 20240723
20240723170246
ACCESSION NUMBER: 0001156039-24-000109
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240722
FILED AS OF DATE: 20240723
DATE AS OF CHANGE: 20240723
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOUDREAUX GAIL
CENTRAL INDEX KEY: 0001287920
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16751
FILM NUMBER: 241135326
MAIL ADDRESS:
STREET 1: GENZYME CORP.
STREET 2: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elevance Health, Inc.
CENTRAL INDEX KEY: 0001156039
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 352145715
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 220 VIRGINIA AVENUE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
BUSINESS PHONE: 8003311476
MAIL ADDRESS:
STREET 1: 220 VIRGINIA AVENUE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
FORMER COMPANY:
FORMER CONFORMED NAME: Anthem, Inc.
DATE OF NAME CHANGE: 20141202
FORMER COMPANY:
FORMER CONFORMED NAME: WELLPOINT, INC
DATE OF NAME CHANGE: 20100105
FORMER COMPANY:
FORMER CONFORMED NAME: WELLPOINT INC
DATE OF NAME CHANGE: 20041130
4
1
wk-form4_1721768559.xml
FORM 4
X0508
4
2024-07-22
0
0001156039
Elevance Health, Inc.
ELV
0001287920
BOUDREAUX GAIL
220 VIRGINIA AVENUE
INDIANAPOLIS
IN
46204
1
1
0
0
President and CEO
1
Common Stock
2024-07-22
4
S
0
1100
498.50
D
159609
D
Common Stock
2024-07-22
4
S
0
20779
500.36
D
138830
D
Common Stock
2024-07-22
4
S
0
6621
501.40
D
132209
D
Common Stock
2024-07-22
4
S
0
2250
502.23
D
129959
D
Common Stock
2024-07-22
4
S
0
1000
503.67
D
128959
D
Common Stock
2024-07-22
4
S
0
2250
504.27
D
126709
D
Common Stock
60
I
Shares Held in Spouse's Revocable Trust
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024.
This transaction was executed in multiple trades at prices ranging from $499.82 to $500.81. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $500.83 to $501.79. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $501.96 to $502.65. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $503.05 to $503.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $504.1 to $504.99. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Kathleen S. Kiefer, Attorney in fact
2024-07-23